When we take medications, we rely on the manufacturer to provide us with safe and effective products. Unfortunately, that is not always the case. Elmiron has been prescribed to treat interstitial cystitis, a painful bladder condition, for years. However, recent studies have shown a correlation between long-term Elmiron use and devastating vision damage.

Elmiron is a drug developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, and has been on the market since the 1990s. It has been widely used to treat interstitial cystitis, a bladder condition that causes bladder pain and urgency. While Elmiron has been helpful for managing the condition, recent studies have shown that it may cause serious vision problems, including maculopathy and other retinal disorders.


New Studies Reveal Growing Body of Evidence


In response to these studies, patients who have taken Elmiron are suing Janssen Pharmaceuticals for failing to warn them of the potential risks associated with the drug. Additionally, the plaintiffs allege that the manufacturer did not disclose the risk of developing serious vision problems on Elmiron’s list of side effects and warnings. As a result of this omission, many patients have suffered irreversible vision damage.

Currently, there are several cases pending in court against Janssen Pharmaceuticals. The Elmiron lawsuit alleges that the manufacturer knew about the risks associated with Elmiron but did not disclose them to patients and healthcare providers. Moreover, the lawsuits also accuse Janssen Pharmaceuticals of failing to conduct adequate safety studies on the drug.


Uncovering the Risks of Elmiron


Several studies linking the long-term use of Elmiron to vision-related problems have emerged.


1. Maculopathy: One study published in the Journal of Urology found that approximately 25% of IC patients who took Elmiron for extended periods developed maculopathy—a retinal disorder impairing central vision.

2. Higher Risk: Another research conducted by Emory Eye Center found that patients taking Elmiron for over three years had a higher risk of developing vision issues.


Growing Body of Evidence


Presenting their research at the American Academy of Ophthalmology, experts and physicians offered strong support for the connection between long-term PPS use and toxic maculopathy development.


Impact on Vision


Elmiron affects the macula, which is responsible for sensing light and transmitting signals to the brain. Maculopathy caused by Elmiron can potentially lead to blindness if the drug use persists.


Specific Concerns


Elmiron has been linked to pigmentary maculopathy, and long-term effects on sight remain uninvestigated. The only potential solution is to suspend the drug’s use and monitor macular damage.


Early Detection and Symptoms


Early detection of Elmiron-linked macular damage is crucial. Symptoms include noticeable areas of vision loss, difficulty adjusting to light changes, reading difficulties, impaired close-up vision, and dimming of vision. Contact your doctor or ophthalmologist immediately if you experience any of these symptoms while taking Elmiron.


Gain Justice & Compensation for Vision Issues Triggered by Elmiron


Immediate medical attention should be sought if you or someone you know has experienced vision problems after taking Elmiron. Our attorneys in Toledo, Ohio, are experienced in reviewing medical records and providing guidance for filing a case in association with the Elmiron Lawsuit. Our dedicated attorneys at Gallon, Takacs, & Boissoneault represent patients harmed by Elmiron.

In addition, compensation may be available for severe vision issues resulting from long-term use of Elmiron. We also provide assistance in navigating the legal process and fighting for justice and compensation. Expect effective representation in court from our experienced attorneys. To determine eligibility in the Elmiron Lawsuit, please complete our free case evaluation form. Remember, help is available, and you are not alone.